Melanotan II 1 mg/mL (10 mL) Injection, 10mL vials, Rx only, Farmakeio 1736 N Greenville Ave Rich...

FDA Drug Recall #D-0779-2022 — Class II — April 5, 2022

Recall Summary

Recall Number D-0779-2022
Classification Class II — Moderate risk
Date Initiated April 5, 2022
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding
Location Richardson, TX
Product Type Drugs
Quantity 35 vials

Product Description

Melanotan II 1 mg/mL (10 mL) Injection, 10mL vials, Rx only, Farmakeio 1736 N Greenville Ave Richardson, TX 75081 USA

Reason for Recall

Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.

Distribution Pattern

Nationwide within United States

Lot / Code Information

Lot #: 32610 BUD: 4/4/2022; 35126 BUD: 6/7/2022

Other Recalls from North American Custom Laboratories, L...

Recall # Classification Product Date
D-0780-2022 Class II PT-141 (Bremelanotide Acetate) 10 mg/mL (2 mL) ... Apr 5, 2022
D-0775-2022 Class II ARA-290 (Cibinetide Acetate) 6 mg/mL (4 mL) Inj... Apr 5, 2022
D-0777-2022 Class II Ipamorelin Acetate/Sermorelin Acetate (1 mg/1 m... Apr 5, 2022
D-0781-2022 Class II Sermorelin Acetate 1 mg/mL (6 mL) Injection, 6 ... Apr 5, 2022
D-0776-2022 Class II BPC-157 2 mg/mL (5 mL) Injection, 5 mL vials, R... Apr 5, 2022

Frequently Asked Questions

cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.